Skip to content
healthcare.dev

Eribulin Mesylate

NDC 43598-125, Eribulin Mesylate, injection, from Dr. Reddys Laboratories Inc.

Product NDC
43598-125
Status
Listed
Labeler
Dr. Reddys Laboratories Inc
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217473
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43598-125 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ERIBULIN MESYLATE.5 mg/mL

Pharmacologic classes

Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]

Package NDCNDC-11Package
43598-125-11435980125111 VIAL, SINGLE-DOSE in 1 CARTON (43598-125-11) / 2 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1038e984-3bf7-5bbf-f1ec-ce15ae330efc
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=43598-125

Use it

Look up 43598-125 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43598-125 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43598-125. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.